Pharmaceutical Products Price Equity Act

Fact Sheet API

Bill Number

HR 608

Introduced

Feb 5, 2003

Latest Action

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Sponsor

Cosponsors

Topics

Administrative procedure Administrative remedies Civil actions and liability Class actions (Civil procedure) Commerce Crime and Law Enforcement Damages Drug industry Economics and Public Finance Fines (Penalties) Government Operations and Politics Health Injunctions Law Legal fees Prescription pricing Price discrimination Price regulation Punitive damages

Full Text

View Full Bill Text

Votes

Summary

Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements, to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.

Actions

Mar 6, 2003

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
Feb 14, 2003

Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
Feb 5, 2003

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 5, 2003

Introduced in House

Amendments

Related Bills